AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation

Part of paid clinical trials in Buffalo, New York.

Sponsor
State University of New York at Buffalo
Study ID
NCT06965296
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Nicotine Dependence, Cigarettes

Eligibility Criteria

Sex
ALL
Age
14 Years - 20 Years
Healthy Volunteers
Not accepted

Interventions

  • AI-enhanced smartphone app — BEHAVIORAL
    A smartphone app has been developed and is in keeping with guideline recommendations for the treatment of e-cigarette products. This app has a user-friendly Graphic User Interface (GUI) to allow users to build their own accounts and individualized contents conveniently, based on the input the users initially provide including e-cigarette use patterns, readiness to quit e-cigarette, beliefs about e-cigarette, nicotine addiction, self-efficacy, other substance use status, and parental or peer e-cigarette use status. The proposed AI model in this app will learn information from the input data, including progress toward e-cigarette cessation (e,g, changes of readiness of quitting, quit attempts), and additional data including emotional status, stress level, feedback to the previous learning modules, and then predict the result on the fly. Based on the predicted result, the app will send in-time motivational messages and mindfulness training modules.
  • AI-enhanced smartphone app, but with delayed access — BEHAVIORAL
    Participants in the control group will be placed on a three-month waitlist. After this period, they will receive access to the same app-based intervention as the immediate intervention group, allowing a comparison between immediate and delayed access.

Study Details

The goal of this quasi-experimental study is to test if a smartphone app can help adolescents aged 14-20 quit e-cigarettes. The main questions it aims to answer are: * Can the app help adolescents manage cravings and increase their readiness to quit? * Does the personalized and real-time support provided by the app improve their success in quitting e-cigarettes? Researchers will compare two groups: an immediate-intervention group that starts using the app right away and a delayed-intervention group that begins after three months, to see if the timing of app access influences outcomes in e-cigarette cessation. Participants will: * Set personal goals and track their daily progress within the app. * Use a real-time "urge" feature that provides immediate support during cravings. * Engage with a chatbot for quick answers and motivational support around quitting. This study aims to create an accessible, personalized tool to help adolescents reduce or quit e-cigarette use, exploring its feasibility as a broader intervention model.

Key Dates

Start date
Apr 1, 2026
Status verified
Feb 2026
Primary completion
Dec 31, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Immediate-Intervention Group
    Participants in this arm will begin using the AI-enhanced smartphone app immediately after enrollment. This arm serves to assess the initial impact and feasibility of the app as a tool for e-cigarette cessation among adolescents.
  • Active Comparator: Delayed-Intervention Group
    Participants in this arm will wait three months after enrollment before using the AI-enhanced smartphone app. This arm serves as a delayed control, allowing comparison with the immediate-intervention group to understand the impact of timing on quitting success.

Primary Outcome Measure

Usability [ Time Frame: 30-Day Follow-up ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University at Buffalo, School of NursingBuffaloNew York14214
Eunhee Park, PhD, RN, APHN-BC
716-829-3701
Eunhee Park, PhD, RN, APHN-BC (PRINCIPAL_INVESTIGATOR)

Find similar trials in Buffalo, NY

Related Studies